Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2

Molecular Microbiology

Volumn 62, Issue 1, 2006, Pages 170-186

  Holmes, Ann R ^a   Tsao, Sarah ^a,d   Ong, Soo Wee ^a   Lamping, Erwin ^a   Niimi, Kyoko ^a   Monk, Brian C ^a   Niimi, Masakazu ^b   Kaneko, Aki ^b   Holland, Barbara R ^c   Schmid, Jan ^c   Cannon, Richard D ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c MASSEY UNIVERSITY   (New Zealand)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA; FUNGAL PROTEIN; PROTEIN CDR1P; PROTEIN CDR2P; PYRROLE DERIVATIVE; RHODAMINE 6G; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; FUNGAL GENE; HETEROZYGOSITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZOLES; BLOTTING, WESTERN; CANDIDA ALBICANS; CLONING, MOLECULAR; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENETIC VARIATION; HETEROZYGOTE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 33748672708     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2006.05357.x     Document Type: Article

References (73)

1. Albertson. G.D., Niimi, M., Cannon, R.D., and Jenkinson, H.F. (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40: 2835-2841.
2. Arnaud, M.B., Costanzo, M.C., Skrzypek, M.S., Binkley, G., Lane, C., Miyasato, S.R., and Sherlock, G. (2005) The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information. Nucleic Acids Res 33: D358-D363.
3. Chau, A.S., Mendrick, C.A., Sabatelli, F.J., Loebenberg, D., and McNicholas, P.M. (2004) Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob Agents Chemother 48: 2124-2131.
4. Clauser, K.R., Baker, P., and Burlingame, A.L. (1999) Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem 71: 2871-2882.
5. Coste, A.T., Karababa, M., Ischer, F., Bille, J., and Sanglard, D. (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3: 1639-1652.
6. Coste, A.T., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Semelcki, A., et al. (2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172: 2139-2156.
7. Decottignies, A., Grant, A.M., Nichols, J.W., de Wet, H., McIntosh, D.B., and Goffeau, A. (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273: 12612-12622.
8. Egner, R., Bauer, B.E., and Kuchler, K. (2000) The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. Mol Microbiol 35: 1255-1263.
9. Ernst, R., Klemm, R., Schmitt, L., and Kuchler, K. (2005) Yeast ATP-binding cassette transporters: cellular cleaning pumps. Methods Enzymol 400: 460-484.
10. Felsenstein, J. (2004) Inferring Phylogenies. Sunderland, MA: Sinauer Associates.
11. Forche, A., Magee, P.T., Magee, B.B., and May, G. (2004) Genome-wide single-nucleotide polymorphism map for Candida albicans. Eukaryot Cell 3: 705-714.
12. Forche, A., May, G., and Magee, P.T. (2005) Demonstration of loss of heterozygosity by single-nucleotide polymorphism microarray analysis and alterations in strain morphology in Candida albicans strains during infection. Eukaryot Cell 4: 156-165.
13. Fundyga, R.E., Lott, T.J., and Arnold, J. (2002) Population structure of Candida albicans, a member of the human flora, as determined by microsatellite loci. Infect Genet Evol 2: 57-68.
14. Gaur, M., Choudhury, D., and Prasad, R. (2005) Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol 9: 3-15.
15. Gauthier, C., Weber, S., Alarco, A.M., Alqawi, O., Daoud, R., Georges, E., and Raymond, M. (2003) Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob Agents Chemother 47: 1543-1554.
16. Graser, Y., Volovsek, M., Arrington, J., Schonian, G., Presber, W., Mitchell, T.G., and Vilgalys, R. (1996) Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc Natl Acad Sci USA 93: 12473-12477.
17. Hernaez, M.L. Gil, C. Pla, J., and Nombela, C. (1998) Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals. Yeast 14: 517-526.
18. Holland, B. Huber, K. Dress, A., and Moulton, V. (2002) Delta-plots: a tool for analyzing phylogenetic distance data. Mol Biol Evol 19: 2051-2059.
19. Hull, C.M., and Johnson, A.D. (1999) Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 285: 1271-1275.
20. Hull, C.M. Raisner, R.M., and Johnson, A.D. (2000) Evidence for mating of the 'asexual' yeast Candida albicans in a mammalian host. Science 289: 307-310.
21. Ishikawa, T. Onishi, Y. Hirano, H. Oosumi, K. Nagakura, M., and Tarui, S. (2004) Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1). Biol Pharm Bull 27: 939-948.
22. Jha, S. Karnani, N. Dhar, S.K. Mukhopadhayay, K. Shukla, S. Saini, P., et al. (2003a) Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. Biochemistry 42: 10822-10832.
23. Jha, S., Karnani, N., Lynn, A.M., and Prasad, R. (2003b) Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Biochem Biophys Res Commun 310: 869-875.
24. Jha, S., Dabas, N., Karnani, N., Saini, P., and Prasad, R. (2004) ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry. FEMS Yeast Res 5: 63-72.
25. Jones, J.L., Hanson, D.L., Dworkin, M.S., Alderton, D.L., Fleming, P.L., Kaplan, J.E., and Ward, J. (1999) Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 48: 1-22.
26. Jones, P.M., and George, A.M. (2002) Mechanism of ABC transporters: a molecular dynamics simulation of a well characterized nucleotide-binding subunit. Proc Natl Acad Sci USA 99: 12639-12644.
27. Jones, T., Federspiel, N.A., Chibana, H., Dungan, J., Kalman, S., Magee, B.B., et al. (2004) The diploid genome sequence of Candida albicans. Proc Natl Acad Sci USA 101: 7329-7334.
28. Karababa, M., Coste, A.T., Rognon, B., Bille, J., and Sanglard, D. (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48: 3064-3079.
29. Laemmli, U.K., and Quittner, S.F. (1974) Maturation of the head of bacteriophage T4. IV. The proteins of the core of the tubular polyheads and in vitro cleavage of the head proteins. Virology 62: 483-499.
30. Legrand, M., Lephart, P., Forche, A., Mueller, F.M., Walsh, T., Magee, P.T., and Magee, B.B. (2004) Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation. Mol Microbiol 52: 1451-1462.
31. Liu, T.T., Lee, R.E., Barker, K.S., Wei, L., Homayouni, R., and Rogers, P.D. (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226-2236.
32. Loo, T.W., and Clarke, D.M. (2002) Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein. J Biol Chem 277: 44332-44338.
33. Maebashi, K., Niimi, M., Kudoh, M., Fischer, F.J., Makimura, K., Niimi, K., et al. (2001) Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J Antimicrob Chemother 47: 527-536.
34. Magee, B.B., and Magee, P.T. (2000) Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains. Science 289: 310-313.
35. Magee, P.T., and Magee, B.B. (2004) Through a glass opaquely: the biological significance of mating in Candida albicans. Curr Opin Microbiol 7: 661-665.
36. Mamnun, Y.M., Schuller, C., and Kuchler, K. (2004) Expression regulation of the yeast PDR5 ATP-binding cassette (ABC) transporter suggests a role in cellular detoxification during the exponential growth phase. FEBS Lett 559: 111-117.
37. Marchler-Bauer, A., Anderson, J.B., Cherukuri, P.F., DeWeese-Scott, C., Geer, L.Y., Gwadz, M., et al. (2005) CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res 33: D192-D196.
38. Marr, K.A., Lyons, C.N., Ha, K., Rustad, T.R., and White, T.C. (2001) Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob Agents Chemother 45: 52-59.
39. Miyazaki, Y., Geber, A., Miyazaki, H., Falconer, D., Parkinson, T., Hitchcock, C., et al. (1999) Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans. Gene 236: 43-51.
40. Monk, B.C., Cannon, R.D., Nakamura, K., Niimi, M., Niimi, K., Harding, D.R.K., et al. (2002) Membrane protein expression system and its application. International Patent PCT/NZ02/00163.
41. Moorhead, S.M., Dykes, G.A., and Cursons, R.T. (2003) An SNP-based PCR assay to differentiate between Listeria monocytogenes lineages derived from phylogenetic analysis of the sigB gene. J Microbiol Methods 55: 425-432.
42. Nakamura, K., Niimi, M., Niimi, K., Holmes, A.R., Yates, J.E., Decottignies, A., et al. (2001) Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother 45: 3366-3374.
43. Niimi, K., Harding, D.R., Parshot, R., King, A., Lun, D.J., Decottignies, A., et al. (2004b) Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother 48: 1256-1271.
44. Niimi, M., Nagai, Y., Niimi, K., Wada, S., Cannon, R.D., Uehara, Y., and Monk, B.C. (2002) Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J Chromatogr B Anal Technol Biomed Life Sci 782: 245-252.
45. Niimi, M., Niimi, K., Takano, Y., Holmes, A.R., Fischer, F.J., Uehara, Y., and Cannon, R.D. (2004a) Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J Antimicrob Chemother 54: 999-1006.
46. Niimi, M., Wada, S., Tanabe, K., Kaneko, A., Takano, Y., Umeyama, T., et al. (2005) Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae. Jpn J Infect Dis 58: 1-7.
47. Pasrija, R., Prasad, T., and Prasad, R. (2005) Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem Soc Trans 33: 1219-1223.
48. Perea, S., Lopez-Ribot, J.L., Kirkpatrick, W.R., McAtee, R.K., Santillan, R.A., Martinez, M., et al. (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 45: 2676-2684.
49. Rogers, P.D., and Barker, K.S. (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 47: 1220-1227.
50. Saini, P., Prasad, T., Akhtar Gaur, N., Shukla, S., Jha, S., Sudha Komath, S., et al. (2005) Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. J Antimicrob Chemother 56: 77-86.
51. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M., and Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386.
52. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
53. Santos, M.A., Keith, G., and Tuite, M.F. (1993) Non-standard translational events in Candida albicans mediated by an unusual seryl-tRNA with a 5′-CAG-3′ (leucine) anticodon. EMBO J 12: 607-616.
54. Schmid, J., Hunter, P.R., White, G.C., Nand, A.K., and Cannon, R.D. (1995) Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens. J Clin Microbiol 33: 2920-2926.
55. Schmid, J., Herd, S., Hunter, P.R., Cannon, R.D., Yasin, M.S., Samad, S., et al. (1999) Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographical regions, patient types and types of infection. Microbiology 145: 2405-2413.
56. Schmitt, L., and Tampe, R. (2002) Structure and mechanism of ABC transporters. Curr Opin Struct Biol 12: 754-760.
57. Schuetzer-Muehlbauer, M., Willinger, B., Egner, R., Ecker, G., and Kuchler, K. (2003a) Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22: 291-300.
58. Schuetzer-Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., and Kuchler, K. (2003b) The Candida albicans Cdr2pATP-binding cassette (ABC) transporter confers resistance to caspofungin. Mol Microbiol 48: 225-235.
59. Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S.V., and Prasad, R. (2003) Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot Cell 2: 1361-1375.
60. Shukla, S., Ambudkar, S.V., and Prasad, R. (2004) Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. J Antimicrob Chemother 54: 38-45.
61. Smriti, Krishnamurthy, S., Dixit, B.L., Gupta, C.M., Milewski, S., and Prasad, R. (2002) ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19: 303-318.
62. Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., and Morschhauser, J. (2002) Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol Microbiol 44: 1351-1366.
63. Tavanti, A., Gow, N.A., Maiden, M.C., Odds, F.C., and Shaw, D.J. (2004) Genetic evidence for recombination in Candida albicans based on haplotype analysis. Fungal Genet Biol 41: 553-562.
64. Tibayrenc, M. (1997) Are Candida albicans natural populations subdivided? Trends Microbiol 5: 253-254; discussion 254-257.
65. White, T.C. (1997a) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487.
66. White, T.C. (1997b) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14a demethylase in Candida albicans. Antimicrob Agents Chemother 41: 1488-1494.
67. Wolfger, H., Mamnun, Y.M., and Kuchler, K. (2004) The yeast Pdr15p ATP-binding cassette (ABC) protein is a general stress response factor implicated in cellular detoxification. J Biol Chem 279: 11593-11599.
68. Wu, W., Pujol, C., Lockhart, S.R., and Soll, D.R. (2005) Chromosome loss followed by duplication is the major mechanism of spontaneous mating-type locus homozygosis in Candida albicans. Genetics 169: 1311-1327.
69. Yang, Z. (1997) PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555-556.
70. Yang, Z., Nielsen, R., Goldman, N., and Pedersen, A.M. (2000) Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431-449.
71. Yesland, K., and Fonzi, W.A. (2000) Allele-specific gene targeting in Candida albicans results from heterology between alleles. Microbiology 146: 2097-2104.
72. Zhang, N., Harrex, A.L., Holland, B.R., Fenton, L.E., Cannon, R.D., and Schmid, J. (2003) Sixty alleles of the ALS7 open reading frame in Candida albicans: ALS7 is a hypermutable contingency locus. Genome Res 13: 2005-2017.
73. Zhao, X., Pujol, C., Soll, D.R., and Hoyer, L.L. (2003) Allelic variation in the contiguous loci encoding Candida albicans ALS5, ALS1, and ALS9. Microbiology 149: 2947-2960.